why choose us

First received: February 29, 2024

Clinical Trial: A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Renal Impairment

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of MK-8527 in Participants With Moderate and Severe Renal Impairment

Brief Summary: The goal of this study is to evaluate the effect of moderate and severe renal impairment (RI) on the pharmacokinetics (PK), safety, and tolerability of MK-8527.There will be no hypothesis testing in the study.

Read more